Tag: life sciences
-
Oral Covid-19 Vaccine Trial Underway
An early-stage clinical trial is underway in South Africa testing the safety of a vaccine in capsule form to prevent Covid-19 disease.
-
CEPI Funds Multi-Variant Covid-19 Vaccine
Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses.
-
Engineered Virus Delivers Brain-Targeted Gene Therapy
Neuroscience researchers designed a process for delivering gene therapies through the blood stream, but targeting only brain cells of lab animals.
-
Messenger RNA Developer ETF Launches
A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA.
-
NIH Opens $1M Maternal Health Diagnostics Challenge
National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions.
-
Trial Shows Nasal Spray Relieves Migraine Pain
Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases.
-
Oxford, GSK Partner on New Tech for Neuro Diseases
GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders.
-
$180M Venture Fund Backing Age-Related Disease Start-Ups
A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics.
-
Covid-19 Antibody Cocktail Trial Request Filed
A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy.
-
Plant-Based Protein Biotech Raises $3M in Seed Funds
A biotechnology start-up producing proteins with more sustainable and less costly plant-based processes is raising $3 million in its seed funding round.